Selank / Semax

Selank / Semax Combination Blend

A balanced anxiolytic-nootropic blend combining Selank’s calming effects with Semax’s cognitive enhancement.

100% 50% · t½ Time → Serum level
Molecular Weight Not specified
Half-Life Varies
Typical Dose 200–400 mcg (combined)
Cycle Length 2–4 weeks

Description

This pre-formulated blend combines Selank (anxiolytic, anti-stress) with Semax (nootropic, BDNF upregulator) in a single vial for convenient intranasal or injectable use. The combination balances Semax’s stimulating cognitive effects with Selank’s calming properties.

Key Characteristics

Molecular Formula

Molecular Weight

Half-Life

Administration Routes

Intranasal (preferred), Subcutaneous injection

Typical Dose

200–400 mcg (combined)

Frequency

1–2x daily

Investigated Benefits

* Benefits based on preclinical/animal research unless otherwise noted.

Mechanism of Action

“A balanced anxiolytic-nootropic blend combining Selank’s calming effects with Semax’s cognitive enhancement.”

Selank modulates GABAergic and serotonergic systems for anxiolysis. Semax upregulates BDNF and activates dopaminergic pathways for cognitive enhancement. Together they provide balanced cognitive enhancement without excessive stimulation or anxiety.

Administration Routes

Intranasal (preferred)

Subcutaneous injection

Key Characteristics

Typical Dose

200–400 mcg (combined)

Frequency

1–2x daily

Cycle Length

2–4 weeks

Administration

Intranasal (preferred)

Protocol Notes

Intranasal administration preferred. Morning dosing recommended. The combination reduces the stimulant side effects of Semax alone while maintaining cognitive benefits.

Reconstitution Guide

Available as nasal spray blend. Injectable: per prescriber instructions.

Storage Information

Refrigerate. Use within 30 days of opening.

Quality & Sourcing Standards

When sourcing Selank / Semax for research purposes, the following quality benchmarks should be verified before use.

Purity:

>98% (verified by HPLC)

Certificate of Analysis (COA):

Must be provided by supplier

Endotoxin Testing:

<0.1 EU/mg (prevents bacterial contamination)

GMP Compliance:

Manufactured in cGMP-certified facility

Third-Party Testing:

Independent lab verification preferred

Storage Information

Refrigerate. Use within 30 days of opening.

FDA Disclaimer

The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.

Research Highlights

1

Both individual components have clinical approval in Russia

2

Combination provides complementary mechanisms

3

BDNF upregulation and anxiolysis demonstrated for individual components

Evidence Level

Primarily animal studies with limited human data. Mechanism is plausible but clinical efficacy is unconfirmed.

Compatible Peptides

Peptides commonly used alongside Tesamorelin / Ipamorelin / MGF for synergistic effects.

BPC-157

A synthetic pentadecapeptide derived from gastric juice with extraordinary tissue healing properties across multiple organ systems.

DSIP

A naturally occurring neuropeptide that promotes deep restorative sleep and modulates stress hormone responses.

Quick Reference

Category

Blends & Combos

Status

Research Only

Dose

200–400 mcg (combined)

Frequency

1–2x daily

Cycle

2–4 weeks